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Abstract
LIM-domain only protein 4 (LMO4) is a widely expressed protein with important roles in embryonic development and breast
cancer. It has been reported to bind many partners, including the transcription factor Deformed epidermal autoregulatory
factor-1 (DEAF1), with which LMO4 shares many biological parallels. We used yeast two-hybrid assays to show that DEAF1
binds both LIM domains of LMO4 and that DEAF1 binds the same face on LMO4 as two other LMO4-binding partners,
namely LIM domain binding protein 1 (LDB1) and C-terminal binding protein interacting protein (CtIP/RBBP8). Mutagenic
screening analysed by the same method, indicates that the key residues in the interaction lie in LMO4LIM2 and the N-
terminal half of the LMO4-binding domain in DEAF1. We generated a stable LMO4LIM2-DEAF1 complex and determined the
solution structure of that complex. Although the LMO4-binding domain from DEAF1 is intrinsically disordered, it becomes
structured on binding. The structure confirms that LDB1, CtIP and DEAF1 all bind to the same face on LMO4. LMO4 appears
to form a hub in protein-protein interaction networks, linking numerous pathways within cells. Competitive binding for
LMO4 therefore most likely provides a level of regulation between those different pathways.
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Introduction
LMO4 is a member of the LIM-only protein family (LMO1–4)
of metazoan transcriptional co-regulators, and has important roles
in neural and skeletal development [1,2,3]. It is overexpressed in
greater than 50% of sporadic breast cancers and overexpression is
correlated with a poor outcome [4,5]. Although LMO proteins are
known to regulate gene transcription, they do not bind DNA
directly. Rather, they use their protein-interacting LIM (Lin-11/
Isl1/Mec-3) domains to make simultaneous contacts with two or
more other proteins that do bind to DNA, such as GATA1 and
basic helix-loop-helix (bHLH) proteins [6,7]. Interaction of these
LIM domains with the adaptor protein LIM domain binding
protein 1 (LDB1/CLIM2/NLI) facilitates long range chromatin
interactions (e.g., [8,9,10,11]) via the self association of LDB1
[12,13,14].
Whereas LMO1–3 have relatively restricted expression patterns
and can sometimes substitute for each other [15], LMO4, the most
divergent member of the LMO family, is expressed much more
broadly and appears to have a correspondingly broader range of
interaction partners. Reported binding partners include LDB1
[16,17], GATA6 [18], the tumour suppressor CtIP/RBBP8
[19,20,21], the bHLH proteins HEN1 [22] and neurogenin-2
[23], estrogen receptor-a [24], the membrane receptor protein
neogenin [25], protein tyrosine phosphatase 1B (PTP1B) [26], the
transforming growth factor b family member BMP7 [27], the
transcription factor DEAF1 [28], and components of a nucleo-
some-remodelling complex (HDAC1, HDAC2 and MTA1) [24].
In line with the wide range of reported partners, LMO4 has
diverse functions in normal and diseased states. During mouse
embryogenesis it is involved in closing the neural tube during
gastrulation [1,3], anterior-posterior patterning [1], development
of the inner ear [13], neural development [29] and sex
determination [30]. In adult mice it is implicated in memory
and learning [31], insulin secretion and sensitivity [26,32],
adipogenesis [33] and the development of mammary glands
during pregnancy [4]. LMO4 also appears to regulate the cell
cycle and can localise to centrosomes [34]. Aside from breast
cancer, LMO4 is overexpressed in non-small-cell lung cancer [35].
Overexpression of LMO4 is associated with good prognosis in
pancreatic cancer [36], whereas decreases in expression have been
correlated with aggressive meningioma [37], hormone-refractory
recurrent prostate cancer [38] and Alzheimer’s disease [39,40].
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Establishing the mechanisms by which LMO4 binds its partner
proteins will help us understand how LMO4 contributes to these
activities, and how these activities may be connected. However, of
the many known protein partners of LMO4, to date only
interactions with LDB1 and CtIP have been physically char-
acterised.
The LIM-interacting domain (residues 300–330) of LDB1
(LDB1LID), which is intrinsically disordered in isolation, forms b-
zippers that augment the b-hairpins in each LIM domain [41] of
the tandem LIM domains of LMO4 (LMO4LIM1+2). The proteins
bind each other in a head-to-tail manner, that is, with the C-
terminus of one protein proximal to the N-terminus of the other
[42,43,44]. An analogous complex is formed between the first LIM
domain from LMO4 (LMO4LIM1) and residues 664–674 of
CtIP641–685, which also appears to be intrinsically disordered in
isolation [19]. LMO4NLDB1, LMO4NDEAF1 and etc. are used
herein to designate engineered tethered complexes in which ‘‘N’’
represents a Gly/Ser linker. The name order reflects the order of
the domains in the construct. The structures of LMO4LIM1NLDB1
and CtIP664–674NLMO4LIM1 overlay well; it is clear that LDB1LID
and CtIP664–674 bind LMO4LIM1 in an identical manner, despite
low sequence identity. These overlapping binding sites and other
experimental data indicate that the binding of CtIP or LDB1 to
LMO4 is mutually exclusive and, when all are present in the same
location, CtIP and LDB1 must compete for binding to LMO4
[19].
DEAF1 exhibits many biological parallels with LMO4,
suggesting that the reported interaction has important biological
roles. Both proteins contribute to anterior-posterior patterning and
neural tube closure in the developing mouse [1]. Like LMO4,
DEAF1 is involved in insulin signalling [45], onset of Type 1
diabetes [46], cognitive [47,48] and mood disorders [49]. They are
co-expressed in multiple cell types [17,50] and have similar knock-
in or knock-out phenotypes. Further, overexpression of either
protein enhances the proliferation of breast epithelial cells [4,51].
We previously reported that LMO4 binds a putatively
disordered region in DEAF1 (DEAF1404–438). This region of
DEAF1 lies close to a coiled-coil domain that forms tetramers in
vitro [52], and encompasses the nuclear export signal (NES) [53].
In addition, we conducted cell-based localisation studies using
constructs spanning the LMO4-interacting domain, NES and
coiled-coil domains of DEAF1 to show that LMO4 likely
modulates the sub-cellular localisation of DEAF1. Here we
address the molecular basis for complex formation by LMO4
and DEAF1. We show using the yeast two-hybrid assay that both
LIM domains of LMO4 are required for the interaction, and that
the LIM2 domain of LMO4 (LMO4LIM2) and the N-terminal
region from DEAF1404–438 are the major determinants of binding.
We generated a stable complex comprising these domains, and
determined its solution structure. The structure reveals that
DEAF1 binds LMO4LIM2 in an extended head-to-tail conforma-
tion, contacting the same face on LMO4 as LDB1, and
demonstrates that a common mode of binding to LMO4 exists
for DEAF1, CtIP and LDB1. Our data suggest that competition
for binding to LMO4 is a common feature of LMO4-binding
partners, and over- or under-expression of LMO4 can disrupt
multiple networks of interactions within cells to promote disease.
Materials and Methods
Cloning
Residue numbering refers to mouse LMO4 and DEAF1 (NCBI
accession numbers: NP_001155241 and NM_016874, respec-
tively). pGBT9 yeast two-hybrid plasmids encoding LMO4,
LMO4LIM1 and LMO4LIM2, and pGBT9-LMO4NLDB1 were
described previously [19,43]. A yeast two-hybrid plasmid encoding
DEAF145–566 was a gift from Jane Visvader. Vectors containing
inserts encoding surface mutants of LMO4 [19] were sub-cloned
into pGAD10. DEAF1 mutants were generated using overlap
extension PCR on the background template DEAF1404–438_457–479
[52]. L4-DEAF1 (DEAF1404–438 containing a T435D mutation
and a polyproline C-terminal tail) was cloned into the plasmid
pRSET-A.
Yeast two-hybrid assays
Yeast two-hybrid assays were conducted as described previously
[43]. Saccharomyces cerevisiae strain AH109 (Clontech) were co-
transformed and plated on solid media lacking leucine and
tryptophan (–L/–W; growth). Liquid cultures of co-transformed
yeast were serially diluted (A600 nm = 0.2, 0.02 and 0.002) and
spotted (2 mL) on plates that also lacked histidine (2L/2W/2H;
low stringency), and included 0.5 mM 3-amino-1,2,4,-triazol (2
L/2W/2H + 3-AT; medium stringency), or excluded adenine (2
L/2W/2H/–A; high stringency), as well as growth control plates.
Production of recombinant protein
The tethered complexes LMO4LIM2NDEAF1404–418, and
DEAF1404–418NLMO4LIM2 were produced as described previously
for LMO4LIM2NDEAF1404–418 [54]. In these two constructs LIM2
corresponds to LMO477–147 and LMO483–147, respectively. L4-
DEAF1 was produced as a hexahistidine-tagged construct in
Escherichia coli expression strain Rosetta 2 (Novagen). Cells were
cultured in rich media or, for isotopic labelling, in minimal media
containing 15NH4Cl as the sole nitrogen source. Expression was
induced with 1 mM isopropyl-b-D-thiogalacto-pyranoside (IPTG)
at 37 uC for 4 h. The cells were lysed under denaturing conditions
in buffer A (20 mM Tris-base at pH 8.0, 150 mM NaCl and
20 mM imidazole) containing 8 M guanidine-HCl. Cleared lysate
was incubated with Ni-NTA resin for 1 h at 4 uC. The resin was
washed with buffer A containing 6 M urea and then with buffer A
containing 2 mM CaCl2. The peptide was treated with thrombin
on resin overnight at room temperature and eluted with buffer A.
The acidified eluate was applied to a preparative C18 reversed-
phase HPLC column. A gradient of acetonitrile was applied over a
background of 0.1% TFA in MilliQ-water. The protein was
lyophilised, and redissolved in buffers as required.
NMR experiments and structure determination
Chemical shifts for LMO4LIM2NDEAF1404–418, in 20 mM
sodium acetate at pH 5.0, 35 mM NaCl, 0.5 mM TCEP-HCl,
34 mg mL–1 chloramphenicol and Complete EDTA-free protease
inhibitor (one tablet per 50 mL), were assigned using standard
triple resonance NMR experiments as described in [54]. Distance
restraints were obtained from 1H-1H 2D NOESY, 15N-edited
NOESY and 13C-edited NOESY spectra, all with mixing times of
150 ms. NOE peaks were manually picked, checked and corrected
where necessary. The ensemble of structures for LMO4LIM2
NDEAF1404–418 was calculated using ARIA 1.2 implemented in
CNS 1.21 [55]. Default parameters were used except where stated.
The number of molecular dynamics steps was: initial stage, 40000;
refinement stage, 8000; first cooling step, 40000; and second
cooling step, 8000. The upper limit for NOE distance estimates
was increased by 0.15 A˚ from the default value. A mixing time of
150 ms and a rotational correlation time of 5.16 ns were used to
set relaxation matrix parameters. A zinc patch was included to
define zinc co-ordination geometry (Table 1) based on the
coordinates of the LIM2 domains from LMO4 and LMO2 in
the LMOLIM1+2NLDB1LID (PDB IDs: 1RUT and 2XJY,
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respectively. File S1). In the first iteration 200 structures were
calculated, with 20 structures calculated for each of the 7
intermediate iterations, and 600 structures in the final iteration.
The 50 lowest energy structures from the final iteration were
further refined in a shell of water using the standard ARIA
protocol. Longitudinal (T1), transverse (T2) and heteronuclear
NOE relaxation experiments were performed on 600 mM 15N-
labelled LMO4LIM2NDEAF1404–418 using the Bruker pulse pro-
grams hsqct1etf3gpsi3d, hsqct2etf3gpsi3d and hsqcnoef3gpsi3d,
respectively. The relaxation delays used for measuring 15N-T1
time constants were 0.1, 0.15, 0.2, 0.3, 1, 1.4, 1.5 and 2.2 s and
those for measuring T2 time constants were 17, 34, 51, 68, 85, 102,
136, 153, 170, 221 and 255 ms. The same relaxation experiments
were recorded at 800 MHz except that the T2 relaxation delays at
800 MHz were 16, 32, 48, 64, 80, 96, 128, 144, 160, 208 and
240 ms. Lipari-Szabo ordered parameters (S2) were calculated
using the model-free module (fully automated mode) in relax
[56,57].
Recycle delays of 4 s were used in these experiments. Integrated
peaks were fitted to two-parameter exponentials using the
relaxation analysis module in SPARKY [58]. 1H-15N hetero-
nuclear NOEs were calculated by taking the ratio of cross-peak
intensities with and without proton saturation during relaxation
delays. One-dimensional 1H and two-dimensional 15N-HSQC
spectra of L4-DEAF1 were performed in 20 mM sodium acetate
at pH 5.0 and 35 mM NaCl. Images of structures were generated
Table 1. NMR restraints and refinement statistics for LMO4LIM2DEAF1404–418.
Distance restraints
Total NOE 894
Ambiguous 92
Intra-residue 450
Sequential (|i2j| = 1) 172
Medium-range (|i2j|,5) 45
Long-range (|i2j|$5) 227
S-Zn (2.3 A˚)a 6
N-Zn (2.0 A˚)a 1
O-Zn (2.03 A˚)a 1
Total dihedral angle restraints (TALOS)a
Q 43
y 43
Zinc(II) angle restraintsb
S-Zn-S (112u) 6
C-S-Zn (107u) 6
S-Zn-N (107u) 3
C-N-Zn (125u) 1
S-Zn-O (102u) 3
C-O-Zn (125u) 1
Atomic RMSD (A˚) Backbone Heavy
LMO4LIM2NDEAF1404–418
c 0.691 1.102
LMO4c 0.666 1.102
DEAF1c 0.506 0.891
PROCHECK–Ramachandran Statistics (all)
Most Favoured (%) 73.3
Additionally allowed (%) 23.1
Generously allowed (%) 2.2
Disallowed (%) 1.4
Mean deviations from the ideal geometry
Bond Lengths (A˚) 0.0039060.00023
Bond Angles (u) 0.49360.018
Impropers (u) 1.3560.11
dDistance violations .0.5 A˚ 2
aThere were no dihedral angle violations .5u.
bFull parameter and topology files are included in File S1.
cRegions of LMO4 between residues 86–139 and of DEAF1 between residues 404–414 including S208 of the glycine-serine linker were considered to be structured
because the residues contained within had sum of angle order parameters (Q + y).1.8 except for residues 103–105 of LMO4 and residues 404, 406 and 407 of DEAF1.
dDistance violations were restricted to disordered regions of the protein.
doi:10.1371/journal.pone.0109108.t001
Structure of an LMO4-DEAF1 Complex
PLOS ONE | www.plosone.org 3 October 2014 | Volume 9 | Issue 10 | e109108
using PyMol, simple homology models were generated using
SWISS-MODEL [59] or mutation of residues in PyMol, and the
surface area of the LMO4-DEAF1 interface was calculated using
PISA [60].
Multi-angle laser-light scattering (MALLS)
Purified proteins were subjected to size-exclusion chromatogra-
phy using a Superose-12 10/30 size-exclusion column (GE
Healthcare) with an in-line MiniDawn MALLS detector (Wyatt
Technology) and Wyatt Refractometer. Proteins were eluted in
20 mM Tris-acetate at pH 8.0, 50 mM NaF and 0.5 mM TCEP-
HCl using a flow rate of 0.5 mL min21. The weight-average
molecular weight was calculated using the intensity of scattered
light in combination with the change in refractive index. Protein
concentration at the detector was determined by the change in
refractive index.
Far UV-circular dichroism (CD) spectropolarimetry
The far-UV CD spectrum of L4-DEAF1 (40 mM) buffered in
20 mM Tris-acetate and 50 mM NaF was recorded on a Jasco J-
720 spectropolarimeter at 20uC in a 1-mm quartz cuvette. The
spectrum represents the average of three accumulations collected
at a rate of 20 nm min21. Data were collected at a resolution of
0.5 nm and smoothed over a moving average of five consecutive
data points. Curves were buffer-baseline corrected.
Accession numbers
The coordinates of the 20 lowest energy water-refined structures
of LMO4LIM2NDEAF1404–418 have been deposited in the PDB
with PDB ID: 2MBV. The NMR assignments were previously
deposited in the BMRB (deposition number 18898) [54].
Figure 1. Yeast two-hybrid and mutagenic analysis of LMO4-DEAF1 binding. (A) Data showing the interaction of DEAF145–566 (DEAF1) or
control (empty) with the tandem LIM domains of LMO4 (LMO4), the isolated LIM domains of LMO4 (LIM1 and LIM2) or a pre-formed LMO4NLDB1LID
complex. These were spotted onto low-stringency interaction plates or growth control plates. ‘‘Empty’’ refers to pGAD10 vector lacking an insert. (B)
Summary of yeast two-hybrid work. Surface residues of LMO4 that when mutated strongly affected (red), attenuated (orange) or had no effect (blue)
on interaction with DEAF1 are mapped onto the structure of LMO4NLDB1LID (1RUT). Non-mutated residues are in white, and LDB1LID is shown as dark
sticks. (C) Mutagenic scanning of the minimal LMO4-binding domain of DEAF1 (in the DEAF1404–438_457–479 construct). Residues in DEAF1404–438 were
systematically mutated to alanine or glycine in sets of three (or two) as indicated and analysed for binding to LMO4 using yeast two-hybrid assays.
Co-transformants were spotted onto selective media (low, medium and high stringency plates) as well as growth control plates. The sequence of
DEAF1 is coloured according to whether the mutation strongly affected binding (red), attenuated binding (orange) or had no effect (blue) compared
to wild-type positive control on each plate (‘‘wt’’). Thick white lines indicate separate plates.
doi:10.1371/journal.pone.0109108.g001
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Results
Identification of domains and residues on LMO4
important for binding to DEAF1
Yeast two-hybrid assays were used to test the interaction of
DEAF145–566 with isolated LIM domains of LMO4 (LIM1 and
LIM2). LMO4 was expressed either as a construct containing one
or both LIM domains (LMO4) or as a fusion protein with
LDB1LID which makes an ‘intramolecular complex’ (LMO4NLD-
B1LID). An interaction between LMO4 and DEAF1 was only
observed in the presence of both LIM domains and in the absence
of LDB1LID (Fig. 1a). These data suggest that both LIM domains
are involved in binding DEAF1 and that the presence of LDB1LID
prevents DEAF1 from binding to LMO4. Thus, DEAF1 and
LDB1 share similar binding faces on LMO4, or the presence of
LDB1 induces a conformational change in LMO4 that prevents
DEAF1 binding.
To identify the DEAF1 interaction surface on LMO4, a library
of LMO4 surface mutants was screened for an interaction against
DEAF145–566 using yeast two-hybrid assays (Fig. 1b). The
interaction was considered to be strongly affected if no growth
was observed on medium stringency selection plates (red residues),
and attenuated if growth on these plates was less than that
observed for wild-type LMO4 (orange residues). In general, the
residues for which the interaction was disrupted lie predominantly
on the LDB1-binding face of LMO4 (Fig. 1b), supporting the
idea that a common binding face on LMO4 exists for DEAF1 and
LDB1. Mutated residues for which the interaction was most
strongly affected (i.e., L99, R102, Q104/G105, P124/G125 and
R127) are located on LMO4LIM2, whereas those for which the
interaction was attenuated (R33/F34, Y37, K49, G69 and R74/
S75) are part of LMO4LIM1 (Fig. 1b). Thus, although both LIM
domains of LMO4 are required for the interaction with DEAF1 to
be detected in yeast, the second LIM domain (LIM2) appears to
more important for binding.
Characterisation of the LMO4-interaction domain in
DEAF1
We previously defined the LMO4-interaction domain in
DEAF1 as DEAF1404–438 [52], which is predicted to be
unstructured in the context of the full-length protein [52,53] by
sequence analysis programs that predict order/disorder, PONDR
[61] and IUPred [62], and lacks substantial levels of secondary
structure by JPred3 (which predicts secondary structure based on
sequence) [63]. To identify residues of DEAF1 that are important
for binding LMO4, sequential sets of three residues in DEAF1404–
438 were mutated to alanine (or glycine if the original residue was
alanine) and screened for an interaction with LMO4 by yeast two-
hybrid analysis (Fig. 1c). In general, mutations to the N-terminal
half (404–421) of DEAF1404–438 strongly affected the interaction,
whereas mutations to the C-terminal half had little effect.
We could not produce a recombinant peptide corresponding to
DEAF1404–438 in E. coli. The peptide was either poorly expressed
or was rapidly degraded. Instead, we expressed and purified L4-
DEAF1, a construct of DEAF1404–438 that contains a point
mutation, T435D (originally generated as a pseudo-phosphoryla-
tion mutant for a separate study), and a polyproline tail that was
added to the C-terminus to enhance proteolytic stability [64,65]
(Fig. 2a). NMR experiments and far-UV CD spectropolarimetry
were used to assess the fold of L4-DEAF1. The 15N-HSQC
spectrum shows sharp peaks that cluster between 8–8.5 ppm in the
1H dimension (Fig. 2b). This type of poor dispersion of proton
resonances is a hallmark of intrinsically disordered proteins [66].
The far-UV CD spectrum is also characteristic of a largely
disordered peptide, with a minimum at ,200 nm and negative
signal at 195 nm (Fig. 2c). Thus, DEAF1404–438 is intrinsically
disordered in isolation.
Designing an LMO4-DEAF1 complex
Recombinant forms of LMO4 including either or both LIM
domains tend to be poorly soluble and/or are aggregation prone
unless expressed as a tethered complex in which an interacting
Figure 2. The LMO4-binding domain from DEAF1 is disordered in solution. (A) The sequence of L4-DEAF1 includes residues 404–438 of
DEAF1 (bold), a T435D point mutation (underlined) and a polyproline C-terminal tail (PPPPPR). The two N-terminal residues (GS) are an artefact of the
plasmid and remain after treatment with thrombin. (B) 15N-HSQC spectrum of L4-DEAF1 (160 mM) was recorded in 20 mM sodium acetate at pH 5.0
and 35 mM NaCl at 298 K on a 600 MHz spectrometer equipped with a TCI-cryogenic probehead. (C) The far-UV CD spectrum of L4-DEAF1 (40 mM)
dissolved in 20 mM Tris-acetate at pH 8.0 and 50 mM NaF.
doi:10.1371/journal.pone.0109108.g002
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peptide domain from LDB1 or CtIP is tethered to LMO4 via a
flexible linker [19,43]. We used the same strategy to engineer
LMO4NDEAF1 complexes. A range of different LMO4NDEAF1
complexes were generated that contained both LIM domains of
LMO4 and DEAF1404–438. Although some of these complexes
showed promise in terms of soluble expression and preliminary
structural characterisation (Fig. S1 in File S2), they were not
sufficiently stable for detailed structural characterisation. In
particular, these proteins were prone to proteolytic cleavage at
K418 of DEAF1, as determined by mass spectrometry (Sydney
University Proteomics Research Unit; SUPRU). A K418Q mutant
of LMO4NDEAF1404–438 was generated in an effort to prevent
proteolytic degradation, but this protein was insoluble. Given that
our yeast two-hybrid data indicate that binding is mainly mediated
by LMO4LIM2 and the N-terminal half of DEAF1404–438, we
generated protein constructs that included only these domains. We
engineered these complexes in both orientations (LMO4LIM2
NDEAF1404–418 and DEAF1404–418NLMO4LIM2, where the order of
the domains in the name corresponds to the order in the construct;
Fig. 3a). Both tethered complexes were subjected to size-
exclusion chromatography in combination with multi-angle
laser-light scattering (SEC-MALLS). For both constructs the
theoretical molecular weights (LMO4LIM2NDEAF1404–418 = 10.1 kDa
and DEAF1404–418NLMO4LIM2 = 9.3 kDa) and observed experimen-
tal molecular weights (LMO4LIM2NDEAF1404–418 = 10.760.8 kDa
and DEAF1404–418NLMO4LIM2 = 10.160.6 kDa) were in excellent
agreement, indicating that the proteins are predominantly mono-
meric (Fig. 3c). The 15N-HSQC spectrum of LMO4LIM2NDE
AF1404–418 was of high quality, with most peaks exhibiting similar
intensities, in contrast to the broad range of signal intensities observed
in the 15N-HSQC of DEAF1404–418NLMO4LIM2 (Fig. 3b).
Determining the structure of the second LIM domain of
LMO4 in complex with DEAF1
The NMR spectra of LMO4LIM2NDEAF1404–418 were assigned
as described previously [54] and the structure was determined
using standard solution NMR methods. The structured regions of
the complex are LMO486–139 and DEAF1404–414 (Table 1 and
Figure 3. Engineering tethered LMO4LIM2NDEAF1404–418 and DEAF1404–418NLMO4LIM2 complexes. (A) Schematics of full-length LMO4
(blue) and DEAF1 (orange) and engineered ‘intramolecular complexes’ of LMO4LIM2 and DEAF1404–418. The complexes are tethered via a glycine-serine
linker (red) either from the C-terminus of LMO4 to the N-terminus of DEAF1 or vice versa. SAND, coiled-coil (CC) and MYND domains, and nuclear
localisation (NLS) and nuclear export (NES) signals in DEAF1 and the LIM1 and LIM2 domains in LMO4 are indicated. (B) MALLS analysis of tethered
constructs as indicated; protein concentrations at the detectors are 30 mM. Lines represent the refractive index and calculated molecular weights are
shown as symbols. Monomeric BSA (blue) was used as a standard. (C) 15N-HSQC spectra of LMO4LIM2NDEAF1404–418 (black) and DEAF1404–
418NLMO4LIM2 (red) were recorded in 20 mM sodium acetate at pH 5.0, 35 mM NaCl and 0.5 mM TCEP-HCl at 298 K on a 600 MHz spectrometer.
doi:10.1371/journal.pone.0109108.g003
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Fig. 4). The r.m.s.d. of these regions in the ensemble is 0.7 A˚ for
backbone atoms and 1.1 A˚ for all heavy atoms. The structure of
LMO4LIM2 is typical of LIM domains [67], which contain two
zinc-binding modules, each of which comprises two orthogonally
arrayed b-hairpins followed by a short helical region of variable
length. In this case the a-helices are short and poorly defined. The
first b-hairpin and helix in each zinc-binding module coordinate
one zinc ion. The first zinc-ion is coordinated by C87, C90, H109
and C112, and the second by C115, C118, C137 and D140
(Fig. 4b). A hydrophobic core is formed by residues from the first
(M101, A103, Q104, Y108 and F113) and second (L122, F54 and
Y56A) zinc-binding modules packing against each other. Apart
from a single residue preceding the N-terminus of DEAF1 (S208),
the glycine-serine linker between LMO4LIM2 and DEAF1404–418,
appears to be disordered (Table 1).
The DEAF1 peptide binds in an extended, head-to-tail
conformation across the length of LMO4LIM2 (Fig. 4a–d),
indicating that this motif, like other LIM-interacting domains,
becomes structured upon binding. The interface between
LMO4LIM2 and DEAF1404–418 buries a surface area of
,1700 A˚2 and complex formation appears to be mediated by
hydrophobic interactions between side-chains (Fig. 4). The side-
chain of residue DEAF1A405 is buried in hydrophobic core of
LMO4LIM2 between the two zinc-binding modules, and a number
of other residues, particularly in the stretch I404–E409, make
surface hydrophobic contacts. In at least half the conformers in the
ensemble, four backbone-backbone hydrogen bonds are formed
between LMO4LIM2 and DEAF1 (Fig. 4e), creating short
segments of b-strand that augment b-hairpins in LMO4. A single
salt bridge formed between DEAF1E406 and LMO4R102 (Fig. 4c
Figure 4. The structure of LMO4LIM2NDEAF1404–418. (A) Overlay of the 20 lowest energy structures. Backbone regions from LMO4LIM2 (blue),
linker (grey) and DEAF1 (yellow) are shown as lines with only Ca atoms shown. Zinc ions (Zn1 and Zn2) appear as grey spheres. (B) Ordered regions of
the lowest energy structure are shown as ribbons, coloured as in panel (A). Side-chains of zinc-coordinating residues are shown as sticks. The linker is
represented as a dashed grey line. (C) LMO4LIM2 is represented as an electrostatic surface. Positively and negatively charged surfaces are coloured
blue and red, respectively. DEAF1 is shown as orange sticks except for nitrogen (blue) and oxygen (red) atoms. Residues of DEAF1 are labelled. The N-
and C-termini of DEAF1 are marked. The salt bridge formed between R102 of LMO4 and E409 of DEAF1 is denoted by a dashed yellow line. (D)
Surface mutations of LMO4 that abrogated (red) its interaction with DEAF1 (yellow sticks) in yeast two-hybrid assays are mapped onto the lowest
energy solution structure of LMO4LIM2NDEAF1404–418. (E) Summary of interactions at the LMO4-DEAF1 interface. Residues from LMO4LIM2 are
positioned directly above or below their interaction partners from DEAF1404–418 (orange) and coloured according to the type of interaction. S208
(grey) of the linker makes contacts in more than half the structures in the final ensemble. Residues S208 from the linker and I404–A410 from DEAF1
and their interactions are indicated with solid lines. Remaining DEAF1 residues and interactions are indicated with dashed lines.
doi:10.1371/journal.pone.0109108.g004
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and 4e) is seen in more than half the structures in the ensemble
and may help define the binding register.
The effect of the tether on the structure of
LMO4LIM2NDEAF1404–418
The use of a tether can place steric restraints on complex
formation. We previously showed that chemical shift data is
consistent with disorder in the linker [54]. Here we used 15N-
NMR relaxation data to assess whether the tether might introduce
strain into the complex, and also to examine the overall dynamics
of the complex. The data indicate that the N- and C-termini and
the glycine-serine linker between LMO4LIM2 and DEAF1404–418,
with the exception of S208, undergo substantial motion, implying
that the linker is flexible and is unlikely to be inducing non-native
interactions (Fig. 5). The relaxation data show localised excur-
sions within the structured region of LMO4 (A86–H139), which
generally correspond to loop regions, such as N120–V123. In
addition, the T1 data for two regions that form short a-helices in
the crystal structure of LMO4NLDB1 (H109–K111 and E138–
D140) indicates relatively dynamic structure, suggesting that these
short helices are transient in solution. Low values of the order
parameter S2 are also observed for several residues within the LIM
domain. These values likely reflect local dynamics; for example,
E98 and G105, which lie in a loop and a b-turn, respectively,
exhibit low S2 values. Collectively these data may report intrinsic
flexibility within LIM domains (e.g., [68,69,70]).
Discussion
The LMO4LIM2-DEAF1 interaction
Although both LIM domains of LMO4 were required to detect
an interaction with DEAF1 in yeast two-hybrid experiments, it was
only possible to determine the structure of a smaller LMO4-
LIM2NDEAF1404–418 tethered complex. However, comparison of
15N-HSQC spectra from an LMO4LIM1+2NDEAF1 complex and
LMO4LIM2NDEAF1404–418 recorded under identical conditions
shows high levels of overlap, consistent with conservation of
structure for LMO4LIM2 and DEAF1 in both constructs (Fig. S2
in File S2). The LMO4LIM2 in this structure is almost identical to
that from the crystal structure of LMO4LIM1+2NLDB1LID
(LMO486–139 from the single molecule in PDB: 1RUT and the
mean structure from PDB: 2MBV give rise to a backbone r.m.s.d
of 1.3 A˚). The tether should stabilise the complex both by reducing
the loss of entropy associated with binding, and by increasing the
effective concentrations of interacting domains. Several pieces of
data suggest that the tether allows a native-like complex between
LMO4 and DEAF1. First, the data from our mutagenic
interaction screens (Table 1 and Fig. 1) are consistent with the
solution structure of the complex. That is, the key residues from
the N-terminal half of DEAF1404–418 and LMO4LIM2 are found at
the LMO4LIM2-DEAF1 interface in the structure (Fig. 4).
LMO4Q104/G105 is a minor exception; these residues form part
of a b-turn that packs against LMO4R102, which in turn forms a
Figure 5. Relaxation analysis of LMO4LIM2NDEAF1404–418. (A) Longitudinal (T1), (B) transverse (T2) relaxation time constants, (C) heteronuclear
NOEs, calculated as the ratio of peak intensities with and without proton saturation, all at 600 MHz. (D) Lipari-Szabo (S2) parameters for each assigned
backbone amide group in LMO4LIM2NDEAF1404–418 calculated from data recorded at 600 MHz and 800 MHz, using the program relax. Error bars
represent one standard deviation from the curve fit for each residue. Background colours indicate regions belonging to LMO4 (blue), DEAF1 (yellow)
or the glycine-serine linker (G/S; grey).
doi:10.1371/journal.pone.0109108.g005
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salt bridge with DEAF1E406. Second, we have previously shown
that increasing the length of the synthetic linker from eight to
eleven residues, or extending the DEAF1 peptide by five residues
in the N-terminal direction does not change the structure of the
complex according to 15N-HSQC spectra [54]. In contrast, we
recently showed, in a closely related system involving the LIM
protein ISL1, that randomising the sequence of a LIM-binding
peptide induced non-specific binding, as evidenced by significant
line broadening in TROSY-15N-HSQC spectra [71] of the
randomised peptide complex, compared to the wild-type peptide
complex.
Although the LMO4LIM2NDEAF1404–418 complex appears
overall to be native-like, the last residue of the synthetic linker,
S208, does mediate contacts with LMO4R127 and LMO4F128 in
more than half of the members of the structural ensemble
(Fig. 4e). Similar contacts could also be mediated by DEAF1Q403,
the residue that would replace S208 in the full sequence of
DEAF1. Thus, DEAF1Q403, and possibly one or two additional
residues from DEAF1, are also likely to be involved in the native
protein interaction interface. Given the NMR data described
above, these residues would be expected to slightly extend rather
than significantly change the nature of the binding interface of the
two proteins.
Whereas the structure of the complex around the tether appears
to be native-like, features near the N-terminus of LMO4LIM2 and
C-terminus of DEAF1404–414 suggest that eliminating the LMO4-
LIM1 domain has had a minor effect on structure. For both this
LMO4LIM2NDEAF1 structure and the related LMO2LIM2NLD-
B1LID complex [72], the first b-hairpins in the LIM2 domains are
poorly defined compared with similar complexes that also contain
a LIM1 domain [6,43,44,73]. This suggests that contacts between
the LIM1 and LIM2 domains stabilise the structure at the N-
terminus of the LIM2 domain. A comparison of the LMO4-
LIM2NDEAF1 structure with LMO4-LDB1 structures (Fig. 6a and
b) shows that the C-terminus of the DEAF1 domain extends into
what would be a structured region in a tandem LIM construct.
Figure 6. Tandem LIM LMO4-DEAF1 interactions. (A) Comparison of the lowest energy member of the LMO4-DEAF1 complex ensemble (LMO4
in grey ribbon with blue labels and DEAF1 as orange sticks with black labels) and the LMO4-LDB1 complex (PDB accession code 1RUT, LMO4 with
white surface and ribbon and LDB1 in magenta). Labels for residues in DEAF1 that clash with LMO4 in the LMO4-LDB1 structure are boxed. (B) Close
up of the clashing region from the previous panel, using the same colouring, but with backbone residues from LMO4-DEAF1 (grey) and LMO4-LDB1
(cyan) shown as sticks and backbone-backbone hydrogen bonds with LMO4I94 shown in the same colours. Only the affected residues are shown for
clarity. (C) Structure-based sequence alignment of characterised LIM-peptide complexes. Residues in bold appear to be important for binding based
on mutational studies, boxed residues have been shown to be buried in the hydrophobic core between the two zinc-binding modules in the relevant
LIM domain, and residues highlighted in yellow are predicted to be buried based on the alignment. LIM-binding motifs are indicated with asterisks.
Residues in the spacer regions are generally not conserved but are shown for completeness. Two binding registers are proposed for the LIM1-binding
residues in DEAF1. (D) Simple model for binding register (i). Structures for LMO4LIM1-CtIP and LMO4LIM2-DEAF1404–410 were aligned over the backbone
atoms of the respective LIM domains in the LMO4-LDB1 structure (1RUT), and the residues in CtIP were altered to the correspond residues in DEAF1
using the mutagenesis module in PyMol. The linker between LIM1 and LIM2 from the LMO4-LDB1 structure is shown as a white cartoon. The
approximate position of DEAF1411–415 is indicated with an orange line. (E) Homology model for binding mode (ii) using the structure of Lhx3–Isl1 as a
template. In all cases where molecules are shown as sticks, nitrogen and oxygen atoms are shown in blue and red, respectively.
doi:10.1371/journal.pone.0109108.g006
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Indeed, in the LMO4LIM1+2NLDB1 structures [43,44], LMO4I94
(which forms a backbone-backbone hydrogen bond with
DEAF1T414 in the structure) forms an intramolecular backbone-
backbone hydrogen bond that would preclude it from making an
intermolecular hydrogen bond with a peptide binding-partner
(Fig. 6b). Apart from that hydrogen bond, there are relatively few
LMO4-DEAF1 contacts in this region of the complex (Fig. 4c
and e). Although it is possible that the interaction between LMO4
and DEAF1 forms an atypical LIM-peptide interface, we think it is
more likely that this region of the interface is an artefact resulting
from construct design. Indeed, 15N-HSQC spectra show conser-
vation of peaks from S208 and DEAF1404–411 for LMO4LIM1+2
and LMO4LIM2 complexes, but no conservation of peaks for
DEAF1 residues that lie C-terminal to DEAF1411 (Fig. S2 in File
S2). Assuming that S208 is a good mimic of DEAF1Q403, there is
high structural homology between DEAF1403–410 and LDB1302–
309, despite poor sequence identity – only DEAF1P408 and
LDB1P307 are identical in the two LMO4 partners (Fig. 6).
The tandem LIM LMO4-DEAF1 interface
All characterised peptide-like LIM-interaction domains bind the
equivalent faces of their target tandem LIM domains using two
linear binding motifs roughly 8–10 residues long. The binding
motifs are separated by a spacer of 1–9 residues [41]. We predict
that the C-terminal portion of DEAF1404–438 will bind LMO4LIM1
in the same fashion as LDB1 and CtIP because our data shows the
same key residues of LMO4 are implicated [19,43,44]. The
mutagenic data for DEAF1 (Fig. 1c) indicate that two other
portions of DEAF1404–438 may contribute to binding: DEAF1419–
421 and DEAF1434–438. The former region forms a small
hydrophobic cluster that is typical of peptide LIM-binding motifs
[41] and, assuming a spacer of ,5–6 residues, would be well
placed to interact with the core binding site on LMO4LIM1.
Spacers of this size are utilised by the Lhx3/4-binding domains of
ISL1 and ISL2 [70,71]. In contrast, the more distal residues
(DEAF1434–438) are predicted to lie outside the LIM-binding motif.
We have seen a similar effect upon mutation of some residues C-
terminal of the LMO4-interaction domain in LDB1 [43] and CtIP
[19]. These mutations might disrupt long-range interactions, but
additional yeast-two hybrid data, in which we assessed the stability
of one of these mutants through interaction with a C-terminal
coiled-coil domain, indicates that these mutations destabilise the
constructs in yeast cells (Fig. S3 in File S2).
Even with the identification of the short hydrophobic cluster
DEAF1I419/V420/L421 as a likely binding motif, it is not possible to
accurately predict the binding register of the LIM1-binding motif.
For example, two possible registers based on those observed for
LMO4-CtIP (where two residues are buried in the hydrophobic
core of the LMO4LIM1 domain) and LMO4-LDB1 and related
Lhx-ISL complexes (where a single residue is buried in the
hydrophobic core of the LMO4LIM1 domain) are shown (Fig. 6).
In the first model of binding (Fig. 6d), the side-chains of
DEAF1I419 and DEAF1L421 are buried in the hydrophobic core
of the protein, DEAF1T422 is correctly positioned to mimic
LDB1T323 and CtIPT671, and DEAF1K418 mimics CtIPK667. In the
second model of binding, which is based on the structure of
Lhx3LIM1+2NISL1LBD, the side-chain of V420 is buried (as is
LDB1I322 or ISL1V282), and DEAF1K418 mimics LDB1R320. At
this stage the mutational data does not allow us to distinguish the
two models. Note that other binding modes are possible, and the
Figure 7. LMO4 is a protein-protein interaction network hub linking multiple cellular processes. Protein-protein interaction network
assembled from data reported for mouse and human LMO4 proteins from the STRING protein-protein interaction database, plus additional papers
cited in the introduction. Bold lines indicate protein-protein interactions that have been characterised structurally. Other lines indicate reported
interactions that have different levels of evidence and some of these lines may represent indirect interactions. Proteins are loosely grouped into
cellular processes.
doi:10.1371/journal.pone.0109108.g007
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angle between the LIM domains is hard to predict. These hinge/
spacer regions vary considerably between LIM-peptide structures
and in many cases show evidence of flexibility [70,71,73,74,75].
Biological Implications
Our data show that DEAF1, LDB1 and CtIP all bind to the
same face on LMO4. If co-expressed and co-localised in a cell,
they would therefore compete for binding to LMO4. LMO4 does
not contain a nuclear localisation sequence (NLS), and is small
enough (,20 kDa) to passively diffuse into and out of the nucleus
[27]. Nuclear localisation of LMO4 and other family members is
likely to be facilitated by binding to partner proteins that contain
NLSs such as the widely expressed LDB1 [17], whose competitive
binding is important for cell specification in a range of tissue types
[76,77,78]. Binding of LMO4 to DEAF1 facilitates nuclear
localisation of DEAF1, apparently through modulation of the
DEAF1 NES [52]. Simultaneously, DEAF1, which contains a
nuclear localisation signal [53], likely facilitates nuclear localisation
of LMO4. DEAF1 probably also sequesters LMO4 at gene
regulatory elements via the DNA-binding SAND domain in
DEAF1. However, whereas other LMO proteins appear to be
predominantly nuclear, LMO4 can be found in either in the
nucleus or distributed between the nucleus and cytoplasm [4,26].
LMO4 can be palmitoylated at its C-terminal cysteine residue
(C165) which facilitates retention of LMO4 in the cytoplasm and
the endoplasmic reticulum [26]. This apparent ability of LMO4 to
associate with membranes and to have a wider subcellular
distribution provides a partial explanation for why LMO4 has a
broader range of reported interaction partners than other LMO
proteins. In terms of protein-protein interaction networks, LMO4
appears be a hub protein, connecting multiple signalling pathways
including cytokine-, TGFb-, leptin-, Ras- and hormone signalling
(Fig. 7). LMO4 has strong links to transcriptional regulation,
either through components of these pathways (e.g., via STAT3
and ESR1) or by mediating contacts with transcription factors
(such as DEAF1, GATA6 and bHLH proteins), co-factor proteins
(such as LDB1) and chromatin remodelling machinery. By
regulating the expression of cyclin proteins [79], and through
interaction with CtIP, LMO4 is likely to contribute to cell cycle
regulation.
Conclusions
DEAF1, Ldb1 and CtIP all appear to bind the same peptide-
binding face on LMO4, suggesting that competitive binding for
LMO4 and modulation of its subcellular localisation, likely plays a
part in linking diverse cellular pathways. Subsequent disruptions to
the normal expression patterns and subcellular localisation of
LMO4 could therefore contribute to severe developmental
abnormalities and breast cancer. Many partners of LMO4 contain
putative intrinsically disordered regions that could contain LMO4-
binding peptides. It will be interesting to determine if many of the
other interaction partners of LMO4 also bind to the same surface.
Supporting Information
File S1 Zinc patch files for NMR structure determina-
tion in ARIA of the LIM2 domain from LMO4. This zip file
includes 8 compressed files: Zinc.param, wellordered.imp, top-
zinc.pro, topallhdg5.3_thz.pro, run.cns, generate_template.ino,
generate_ion1.2.inp, and zinc.pdb.
(ZIP)
File S2 Contains Supplemental data: Figure S1. 15N-
HSQC spectrum of LMO416–148NL4-DEAF1; Figure S2. Over-
lay of 15N-HSQC spectra for LMO4LIM1+2NL4-DEAF1(black) and
LMO4LIM2NDEAF1404–418(blue); and, Figure S3. The 434–36
triple alanine mutant of DEAF1 is destabilised in yeast compared
to wild-type.
(PDF)
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